Abstract
The number of cases of malignant melanoma worldwide is increasing faster than any other form of cancer amongst white-skinned populations [1]. New Zealand and Australia have high ambient UV, Celtic–descent populations, and the highest incidence rates of and mortality rates from cutaneous melanoma in the world [2]. In 2007 in New Zealand, from a total population of four million people, 2173 new cases were registered of melanoma and 292 people died from the disease [3], whereas in Australia, a country of 21 million inhabitants, 10,342 people were diagnosed with melanoma and 1279 died from this disease [4].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150:179–85.
International agency for research on cancer WHO cancer mortality database. [IARC]. 2014. http://www-dep.iarc.fr/WHOdb/WHOdb.htm. Accessed 27 Oct 2014.
New Zealand Health Information Service. Cancer: new registrations and deaths. Wellington: Ministry of Health; 2010.
Sneyd MJ, Cox B. A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world. BMC Cancer. 2013;13:372.
Banfield CC, Redburn JC, Dawber RP. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276–9.
Thomas S, Meng Y, Patel VG, Strayhorn G. A rare form of melanoma masquerading as a diabetic foot ulcer: a case report. Case Rep Endocrinol. 2012;2012:4.
Kong M-F, Jogia R, Jackson S, et al. Malignant melanoma presenting as a foot ulcer. Lancet. 2005;366:1750.
Kong M-F, Jogia R, Srinivasan BT, et al. Malignant melanoma presenting as foot ulcer. Diabetic Med. 2005;22:956–7.
Gregson CL, Allain TJ. Amelanotic malignant melanoma disguised as a diabetic foot ulcer. Diabetic Med. 2004;21:924–7.
Soon SL, Solomon Jr AR, Papadopoulos D, et al. Acral lentiginous melanoma mimicking benign disease: the Emory experience. J Am Acad Dermatol. 2003;48:183–8.
Chang JW, Yeh KY, Wang CH, Yang TS, Chiang HF, Wei FC, Kuo TT, Yang CH. Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res. 2004;14:537–41.
Oettlé AG. In: Della Porto G, Mülbock O, editors. Epidemiology of melanoma in South Africa. Structure and control of the melanoncyte. Berlin: Springer; 1966. p. 292.
Lewis MG. Malignant melanoma in Uganda. Br J Cancer. 1967;21:438.
Green A, McCredie M, MacKie R, et al. A case–control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10(1):21–5.
Takematsu H, Obata M, Tomita Y, Kato T, Takahashi M, Abe R. Subungual melanoma: a clinicopathologic study of 16 Japanese cases. Cancer. 1985;55(11):2725–31.
Möhrle M, Häfner H. Is subungual melanoma related to trauma? Dermatology. 2002;204(4):259–61.
Tan S, Chua H, Lim JTE, Goh CL. Malignant melanoma seen in a tertiary dermatological centre, Singapore. Ann Acad Med Singapore. 2001;30(4):414–8.
Thomas S, Meng Y, Patel VG, Strayhorn G. A rare form of melanoma masquerading as a diabetic foot ulcer: a case report. Case Rep in Endocrinol. 2012;2012(502806):4.
Martin MJ, Hayward R, Viros A, Marais R. Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer Discov. 2012;2(4):344–55.
Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, et al. Metformin blocks melanoma invasion and metastasis development in a AMPK/p53-dependent manner. Mol Cancer Ther. 2013;12:1605–15.
Furney SJ, Turajlic S, Stamp G, Thomas JM, Hayes A, Strauss D, Gavrielides M, Xing W, Gore M, Larkin J, Marais R. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res. 2014;27:835–8.
Bristow IR, et al. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res. 2010;3:25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Paul, S.P., Inskip, M. (2016). Amelanotic Malignant Melanoma of the Toe Presenting as an Ulcer: Management and Biopsy Guidelines. In: Paul, S., Norman, R. (eds) Clinical Cases in Skin Cancer Surgery and Treatment. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20937-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-20937-1_8
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20936-4
Online ISBN: 978-3-319-20937-1
eBook Packages: MedicineMedicine (R0)